Recording: New Horizons for Medical Management of Acromegaly

Join this patient-focused presentation featuring practical case-based learning designed to improve clinicians' understanding of the available treatment options, and discuss the decision process for selecting treatment appropriate to each patient.  

Topics covered will include: 
  • Landscape: What's New and What's Changed 

  • Expanding View: Understanding Patients' Treatment Burden and Experience 

  • A New Horizon: Treatment Options for Optimal Outcomes 

  • The Journey: How to Proceed, the Decision Process 

  • Question and Answer 

 This symposium is certified for 1.0 AMA PRA Category 1 Credits™ and 1.0 ABIM MOC points. 

PLEASE REGISTER THEN CLICK "START" TO: 

  • EVALUATE SESSIONS 
  • CLAIM CME 
  • DOWNLOAD PRESENTATION SLIDES 
  • PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION 

Target Audience

This activity is intended for endocrinologists and endocrine fellows, primary care physicians, physician’s assistants, nurse practitioners and other healthcare professionals. 

Learning Objectives

Upon completion of this educational activity, learners will be able to: 

  • Examine the main aspects of acromegaly, including scientific advances and expanding knowledge of disease pathogenesis, improvements in disease management, and new medical therapies (available and in development) to improve disease control. 

  • Establish familiarity with current research related to patient and medical provider reporting of symptoms during treatment.  
  • Enhance understanding of available treatment options and the consequent outcomes (i.e., control of GH/IGF-I levels, amelioration of signs/symptoms, improved QoL, ease of administration) associated with use of these different treatment options 

Additional Information

Target Audience: 
Physician-in-practice
Fellow
Resident
Clinical researcher
Scientific researcher
Educator/Teacher
Pharmacist
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Other
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
Neuroendocrinology and Pituitary
Level of Outcomes: 
Level 4 (Learning: Competence (Shows How))
Activity summary
Available credit: 
  • 1.00 ABIM MOC
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 CME Certificate of Participation
Course opens: 
10/07/2020
Course expires: 
12/31/2021
Rating: 
0

On-Demand Video
Recorded: Thursday, September 10, 2020 

The format for this symposium provides a patient focused presentation featuring practical case-based learning. The cases are preceded by a brief description of the landscape for patients with acromegaly given by the program chair. Following are 2 sections, each with a case, designed to improve clinicians understanding of patients’ treatment burden and experience, enhance understanding of available treatment options, and discuss the decision process for selecting treatment appropriate to each patient. The final section is a Discussion/Question and Answer opportunity for faculty panel and audience.

Shlomo Melmed, MB ChB - Program Chair 

Professor and Dean 
Cedars-Siani Medical Center 
Los Angeles, CA 

Eliza Geer, MD  

Associate Professor 
Memorial Sloan Kettering 
New York, NY 

Lawrence Katznelson, MD 

Professor 
Stanford University Medical Center 
Palo Alto, CA 

STATEMENT OF INDEPENDENCE

As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society's Special Programs Committee (SPC). The commercial supporter(s) of this activity have no influence over the planning of this CME activity.

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable. 

The faculty reported the following relevant financial relationship(s) during the content development process for this activity: 

  • Shlomo Melmed, MD: Consultant, Chiasma Inc, Ionis, Crinetics, Ipsen; Research Grant Support, Pfizer
  • Laurence Katznelson, MD: Research Grant Support, Chiasma Inc.; Advisory Board, Pfizer
  • Eliza B. Geer, MD: Research Support, Novartis, Strongbridge, Chiasma, Ionis, Bristo-Myers Squibb; Consultant, Chiasma; Advisory Board, Strongbridge

The following SPC member who planned and reviewed content for this activity reported relevant financial relationships:

  • Katherine Araque, MD: Speaker, Novo Nordisk, Inc;   Advisory Expert, Corcept

The following SPC Committee members reported financial relationships: 

  • Andjela T. Drincic, MD: Advisory Board Member, Corcept 

  • Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis 

  • Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences 

  • Amy Rothberg, MD: Spouse, consultant of Merck 

  • Jenny Blau, MD: Employee, AstraZeneca 

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.  

The following SPC members reported no relevant financial relationships: 
Katherine Araque, MD; Beret Ann Casey, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

 

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

DISCLAIMER

The information presented in this activity represents the opinion of the faculty and is not necessarily the official position of the Endocrine Society.

Use of professional judgment: 
The educational content in this activity relates to basic principles of diagnosis and therapy and does not substitute for individual patient assessment based on the health care provider’s examination of the patient and consideration of laboratory data and other factors unique to the patient. Standards in medicine change as new data become available. 
Drugs and dosages:
When prescribing medications, the physician is advised to check the product information sheet accompanying each drug to verify conditions of use and to identify any changes in drug dosage schedule or contraindications.

POLICY ON UNLABELED/OFF-LABEL USE

The Endocrine Society has determined that disclosure of unlabeled/off-label or investigational use of commercial product(s) is informative for audiences and therefore requires this information to be disclosed to the learners at the beginning of the presentation. Uses of specific therapeutic agents, devices, and other products discussed in this educational activity may not be the same as those indicated in product labeling approved by the Food and Drug Administration (FDA). The Endocrine Society requires that any discussions of such “off-label” use be based on scientific research that conforms to generally accepted standards of experimental design, data collection, and data analysis. Before recommending or prescribing any therapeutic agent or device, learners should review the complete prescribing information, including indications, contraindications, warnings, precautions, and adverse events.

PRIVACY AND CONFIDENTIALITY STATEMENT

The Endocrine Society will record learner's personal information as provided on CME evaluations to allow for issuance and tracking of CME certificates. The Endocrine Society may also track aggregate responses to questions in activities and evaluations and use these data to inform the ongoing evaluation and improvement of its CME program. No individual performance data or any other personal information collected from evaluations will be shared with third parties.

COMMERCIAL SUPPORT

This education activity is supported by an independent medical educational grant from Chiasma, Inc.

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.  

The Endocrine Society designates each webinar will to be certified for up to 1 AMA PRA Category 1 Credits and 1 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   For questions about content or obtaining CME credit, please contact the Endocrine Society at education.endocrine.org/contact. 

MAINTENANCE OF CERTIFICATION 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, for each webinar. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

REVIEW YOUR DIPLOMATE ABIM ID NUMBER(S)

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):
    Your ABIM Number: [current-user:profile-profile:field-number-abim]*

    *If your ABIM number is blank or incorrect as shown above, please click the Update button below to add or correct your profile.
  2. Update 

Available Credit

  • 1.00 ABIM MOC
  • 1.00 AMA PRA Category 1 Credits
  • 1.00 CME Certificate of Participation

PLEASE REGISTER THEN CLICK "START" TO: 

  • VIEW PRESENTATIONS
  • EVALUATE SESSIONS 
  • CLAIM CME 
  • DOWNLOAD PRESENTATION SLIDES 
  • PRINT A CERTIFICATE OF ATTENDANCE OR CERTIFICATE OF PARTICIPATION